United States Patent Rights for Apellis Products

In accordance with 35 USC § 287(a), the following list identifies certain Apellis products marketed in the United States and associated U.S. patents. This list may not be exhaustive, and other patents may be pending.

EMPAVELI^® (pegcetacoplan) injection, for subcutaneous use

U.S. Patent No. 7,888,323
U.S. Patent No. 7,989,589
U.S. Patent No. 9,169,307
U.S. Patent No. 10,035,822
U.S. Patent No. 10,125,171
U.S. Patent No. 10,875,893
U.S. Patent No. 11,040,107
U.S. Patent No. 11,292,815

Date: 05/04/22

SYFOVRE^® (pegcetacoplan injection), for intravitreal use

U.S. Patent No. 7,888,323
U.S. Patent No. 7,989,589
U.S. Patent No. 8,168,584
U.S. Patent No. 9,056,076
U.S. Patent No. 9,169,307
U.S. Patent No. 10,035,822
U.S. Patent No. 10,125,171
U.S. Patent No. 10,875,893
U.S. Patent No. 11,292,815

Date: 02/17/23